Implantation of paclitaxel-eluting stents in saphenous vein grafts: clinical and angiographic follow-up results from a multicentre study

Objective: To define the clinical and angiographic follow-up results after implantation of paclitaxel-eluting stents (PESs) in stenotic saphenous vein grafts (SVGs). Design: Prospective multicentre study. Comparison with a control group. Methods: 60 consecutive patients with 65 lesions located in 65...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Heart (British Cardiac Society) 2007-03, Vol.93 (3), p.331-334
Hauptverfasser:	Hoffmann, Rainer, Pohl, Tilmann, Köster, Ralf, Blindt, Ruediger, Boeckstegers, Peter, Heitzer, Thomas
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angioplasty Asian Paclitaxel-Eluting Stent Clinical Trial ASPECT bare metal stent Biological and medical sciences BMS Cardiology. Vascular system Cardiovascular system Case-Control Studies Coronary Angiography Coronary Restenosis - diagnostic imaging Coronary Restenosis - prevention & control Drug dosages Drug Implants ELUTES European evaLUation of pacliTaxel-eluting stent Female Graft Occlusion, Vascular - diagnostic imaging Graft Occlusion, Vascular - prevention & control Heart attacks Humans Immunosuppressive Agents - administration & dosage Interventional Cardiology Investigative techniques, diagnostic techniques (general aspects) MACE major adverse cardiac events Male Medical sciences Middle Aged minimal lumen diameter MLD Multivariate analysis Paclitaxel - administration & dosage paclitaxel-eluting stent PES Prospective Studies Radiodiagnosis. Nmr imagery. Nmr spectrometry Saphenous Vein saphenous vein graft Statistical analysis Stents SVG target lesion revascularisation thrombolysis in myocardial infarction TIMI TLR Veins & arteries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objective: To define the clinical and angiographic follow-up results after implantation of paclitaxel-eluting stents (PESs) in stenotic saphenous vein grafts (SVGs). Design: Prospective multicentre study. Comparison with a control group. Methods: 60 consecutive patients with 65 lesions located in 65 SVGs (mean (SD) age of vein grafts 11.3 (5.7) years) treated with PES (V-Flex Plus, 2.7 μg/mm2 paclitaxel, Cook) and 60 patients with 60 SVG lesions treated with bare metal stent (BMS) were included. Lesions had to be
ISSN:	1355-6037 1468-201X
DOI:	10.1136/hrt.2006.094722